Low-dose rituximab should be used for treating MS in resource-limited settings: Commentary

Mult Scler. 2022 Jun;28(7):1032-1033. doi: 10.1177/13524585221098612.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Immunologic Factors* / therapeutic use
  • Multiple Sclerosis* / drug therapy
  • Rituximab / therapeutic use

Substances

  • Immunologic Factors
  • Rituximab